AHR and metabolic dysfunction-associated steatotic liver disease: According to recent studies, tryptophan metabolites which are potent AHR ligands, have been found to activate AHR, subsequently reducing inflammation and increasing metabolic activity by downregulating de novo lipogenic genes thus ameliorating NAFLD [107,108].